HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients-Reference-Cited by-同舟云学术

HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients

Published:2013-07-31 Issue:7 Volume:8 Page:e70164
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Valcour Victor G.,Ananworanich Jintanat,Agsalda Melissa,Sailasuta Napapon,Chalermchai Thep,Schuetz Alexandra,Shikuma Cecilia,Liang Chin-Yuan,Jirajariyavej Supunee,Sithinamsuwan Pasiri,Tipsuk Somporn,Clifford David B.,Paul Robert,Fletcher James L. K.,Marovich Mary A.,Slike Bonnie M.,DeGruttola Victor,Shiramizu Bruce,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy;O Lambotte;Journal of acquired immune deficiency syndromes,2000

2. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts;C Rouzioux;J Infect Dis,2005

3. HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is;V Avettand-Fenoel;Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology,2008

4. Circulating proviral HIV DNA and HIV-associated dementia;B Shiramizu;Aids,2005

5. HIV proviral DNA associated with decreased neuropsychological function;B Shiramizu;J Neuropsychiatry Clin Neurosci,2007

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. HIV-1 Subtype C Vpr Amino Acid Residue 45Y and Specific Conserved Fragments Are Associated with Neurocognitive Impairment and Markers of Viral Load;AIDS Research and Human Retroviruses;2023-04-01

3. Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus;Open Forum Infectious Diseases;2022-09-01

4. Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND);Current HIV/AIDS Reports;2022-07-22

5. The Role of Pannexin-1 Channels in HIV and NeuroHIV Pathogenesis;Cells;2022-07-20